Increased EpCAM expression in malignant insulinoma: Potential clinical implications

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 391-398

  Raffel, Andreas ^a   Eisenberger, Claus F ^a   Cupisti, Kenko ^a   Schott, Matthias ^a   Baldus, Stephan E ^a   Hoffmann, Imke ^a   Aydin, Feride ^a   Knoefel, Wolfram T ^a   Stoecklein, Nikolas H ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INSULINOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OVERALL SURVIVAL; PANCREAS ISLET; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERINSULINISM; IMMUNOHISTOCHEMISTRY; INSULINOMA; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER;

EID: 75149118964     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0916     Document Type: Article

References (27)

1. de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, Kwekkeboom DJ, Oberg K, Eriksson B, Wiedenmann B, Rindi G, O'Toole D & Ferone D. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006 84 183-188.
2. Vortmeyer AO, Huang S, Lubensky I & Zhuang Z. Non-islet origin of pancreatic islet cell tumors. Journal of Clinical Endocrinology and Metabolism 2004 89 1934-1938.
3. Danforth DN Jr, Gorden P & Brennan MF. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 1984 96 1027-1037.
4. Sarmiento JM & Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surgical Oncology Clinics of North America 2003 12 231-242.
5. Sarmiento JM, Que FG, Grant CS, Thompson GB, Farnell MB & Nagorney DM. Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 2002 132 976-982 (discussion 982-983).
6. Hirshberg B, Cochran C, Skarulis MC, Libutti SK, Alexander HR, Wood BJ, Chang R, Kleiner DE & Gorden P. Malignant insulinoma: spectrum of unusual clinical features. Cancer 2005 104 264-272.
7. Grama D, Eriksson B, Martensson H, Cedermark B, Ahren B, Kristoffersson A, Rastad J, Oberg K & Akerstrom G. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World Journal of Surgery 1992 16 632-639.
8. Balzar M, Winter MJ, de Boer CJ & Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). Journal of Molecular Medicine 1999 77 699-712.
9. Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E & Alberti S. Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenetics and Cell Genetics 2001 92 164-165.
10. Cirulli V, Crisa L, Beattie GM, Mally MI, Lopez AD, Fannon A, Ptasznik A, Inverardi L, Ricordi C, Deerinck T, Ellisman M, Reisfeld RA & Hayek A. KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. Journal of Cell Biology 1998 140 1519-1534.
11. Cirulli V, Ricordi C & Hayek A. E-cadherin NCAM, and EpCAM expression in human fetal pancreata. Transplantation Proceedings 1995 27 3335.
12. Fong D, Steurer M, Obrist P, Barbieri V, Margreiter R, Amberger A, Laimer K, Gastl G, Tzankov A & Spizzo G. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. Journal of Clinical Pathology 2006 61 31-35.
13. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY &Wiedenmann B. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 2006 449 395-401.
14. Stoecklein NH, Luebke AM, Erbersdobler A, Knoefel WT, Schraut W, Verde PE, Stern F, Scheunemann P, Peiper M, Eisenberger CF, Izbicki JR, Klein CA & Hosch SB. Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma. Journal of Clinical Oncology 2004 22 4737-4745.
15. Stoecklein NH, Siegmund A, Scheunemann P, Luebke AM, Erbersdobler A, Verde PE, Eisenberger CF, Peiper M, Rehders A, Esch JS, Knoefel WT & Hosch SB. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer 2006 6 165.
16. Baeuerle PA & Gires O. EpCAM (CD326) finding its role in cancer. British Journal of Cancer 2007 96 417-423.
17. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R, Stopatschinskaya S, Kochli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M, Sauter G & Gastl G. High Ep-CAM expression is associated with poor prognosis in nodepositive breast cancer. Breast Cancer Research and Treatment 2004 86 207-213.
18. Varga M, Obrist P, Schneeberger S, Muhlmann G, Felgel-Farnholz C, Fong D, Zitt M, Brunhuber T, Schafer G, Gastl G & Spizzo G. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clinical Cancer Research 2004 10 3131-3136.
19. Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MH, Han KR, Correa AJ, Eeva M, Tze S, Belldegrun AS & Figlin RA. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clinical Cancer Research 2004 10 2659-2669.
20. Songun I, Litvinov SV, van de Velde CJ, Pals ST, Hermans J & van Krieken JH. Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. British Journal of Cancer 2005 92 1767-1772.
21. Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS & Herlyn D. Colorectal carcinoma invasion inhibition by CO17-1A/ GA733 antigen and its murine homologue. Journal of the National Cancer Institute 1998 90 691-697.
22. Litvinov SV, Bakker HA, Gourevitch MM, Velders MP & Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhesion and Communication 1994 2 417-428.
23. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M & Gires O. Nuclear signalling by tumour-associated antigen EpCAM. Nature Cell Biology 2009 11 162-171.
24. Gonzalez B, Denzel S, Mack B, Conrad M & Gires O. EpCAM is involved in maintenance of the murine ES cell phenotype. Stem Cells 2009 27 1782-1791.
25. Chen Y, Zheng B, Robbins DH, Lewin DN, Mikhitarian K, Graham A, Rumpp L, Glenn T, Gillanders WE, Cole DJ, Lu X, Hoffman BJ & Mitas M. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. International Journal of Cancer 2007 120 1511-1517.
26. Mitas M, Almeida JS, Mikhitarian K, Gillanders WE, Lewin DN, Spyropoulos DD, Hoover L, Graham A, Glenn T, King P, Cole DJ, Hawes R, Reed CE & Hoffman BJ. Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clinical Cancer Research 2005 11 2205-2214.
27. de Sa SV, Correa-Giannella ML, Machado MC, Krogh K, de Almeida MQ, Albergaria Pereira MA, Coelho Siqueira SA, Patzina RA, Ibuki FS, Sogayar MC & Giannella-Neto D. Serpin peptidase inhibitor clade A member 1 as a potential marker for malignancy in insulinomas. Clinical Cancer Research 2007 13 5322-5330.